Krishen, Alok

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 1,177

Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study

Gonzales, D. H., Nides, M. A., Ferry, L. H., Kustra, R. P., Jamerson, B. D., Segall, N., Herrero, L. A., Krishen, A., Sweeney, A., Buaron, K., et al. (2001) · Clinical Pharmacology & Therapeutics

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 143

Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

Hewett, K., Chrzanowski, W., Schmitz, M., Savela, A., Milanova, V, Gee, M., Krishen, A., Millen, L., Leary, M., & Modell, J. (2009) · Journal of Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 57

Meta-Analysis of Suicidality in Placebo-Controlled Clinical Trials of Adults Taking Bupropion

Wightman, D. S., Foster, V. J., Krishen, A., Richard, N. E., & Modell, J. G. (2010) · The Primary Care Companion to The Journal of Clinical Psychiatry

Suicide and Self-Harm StudiesTreatment of Major Depression

Cited by 25

Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: subgroup analysis of a randomized clinical trial

Heffner, J. L., Evins, A. E., Russ, C., Lawrence, D., Ayers, C. R., McRae, T., Aubin, L. S., Krishen, A., West, R., & Anthenelli, R. M. (2019) · Journal of Affective Disorders

Smoking Behavior and CessationBipolar Disorder and Treatment

Cited by 23